04 Nov 2019 --- Pharmako Biotechnologies’ self-micro-emulsifying drug delivery system (SMEDDS) tripled the absorption of Coenzyme Q10 (CoQ10), which acts as an antioxidant to protect cells from damage and to help metabolism. This is according to a study published in the International Journal of Pharmacokinetics, which also found that the system, dubbed AquaCelle, with CoQ10 was equal or better than that of ubiquinol absorption – an electron-rich form of the coenzyme. The company highlights that these findings allow the product to be used in new formats such as beverages, shots, gels and creams due to the reduced dose in combinational formulations.